吉利控股與瑞士Concordium成立區塊鏈技術合資公司
吉利控股集團宣布,與瑞士Concordium基金會簽署合作協議,雙方將在中國設立合資公司,依託Concordium的區塊鏈技術,向包括汽車行業在內的中國客戶提供基於區塊鏈平台的商業模式和分布式應用(DApp),目標成為中國領先的區塊鏈技術與服務供應商。
根據協議,吉利控股和Concordium將分別持有合資公司80%及20%的股份,並共同運營管理。
合資公司將通過研發區塊鏈底層技術,開發區塊鏈行業解決方案,提供區塊鏈服務(BaaS),並專注包括數字身份、監管技術、隱私增強技術在內的前沿技術,協助客戶在各個行業構建區塊鏈應用場景和解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.